Bioanalysis of recombinant proteins and antibodies by mass spectrometry
文献信息
Eric Ezan, Mathieu Dubois, François Becher
In recent years, biotechnologically-derived drugs have been a major focus of research and development in the pharmaceutical industry. Their pharmacokinetics and pharmacokinetic/pharmacodynamic relationships impact every stage of the development process and require their assessment in the circulation in preclinical species and in humans. To this end, immunoassays are a reference, but standardisation remains an issue owing to the restricted pattern of antibody specificity and interference with endogenous components. As an alternative, we report here analytical strategies involving liquid chromatography coupled to mass spectrometry (LC-MS) for the accurate quantification of therapeutic proteins and antibodies in biological fluids.
相关文献
IF 6.222
Microscopic insights into long-range 1D ordering in a dense semi-disordered molecular overlayerIF 6.222
High-performance tungsten carbide electrocatalysts for the hydrogen evolution reactionIF 6.367
The limits to biocatalysis: pushing the envelopeIF 6.222
Novel aqueous amine looping approach for the direct capture, conversion and storage of CO2 to produce magnesium carbonateIF 6.367
Sensitive and specific detection of tumour cells based on a multivalent DNA nanocreeper and a multiplexed fluorescence supersandwichIF 6.222
Strong circularly polarized luminescence of an octahedral chromium(iii) complexIF 6.222
A model-based comparison of Ru and Ni catalysts for the Sabatier reactionIF 6.367
Biomaterials Science Emerging Investigators 2021IF 6.843
Increasing efficiency of perovskite solar cells using low concentrating photovoltaic systemsIF 6.367
来源期刊
Analyst

Analyst publishes analytical and bioanalytical research that reports premier fundamental discoveries and inventions, and the applications of those discoveries, unconfined by traditional discipline barriers.